
Andrew J. Wang
Director (ID: 14764, Phone: (571)272-3750 , Office: P/3700 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1639, 1621, 2628, 1635, 1809 |
| Total Applications | 378 |
| Issued Applications | 235 |
| Pending Applications | 93 |
| Abandoned Applications | 50 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4297922
[patent_doc_number] => 06184352
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Adseverin protein'
[patent_app_type] => 1
[patent_app_number] => 9/469253
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 11821
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184352.pdf
[firstpage_image] =>[orig_patent_app_number] => 469253
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469253 | Adseverin protein | Dec 21, 1999 | Issued |
| 09/449422 | NOVEL HUMAN CYSTEINE PROTEASE | Nov 22, 1999 | Abandoned |
Array
(
[id] => 5967924
[patent_doc_number] => 20020090613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'COLOR-ENCODING AND IN-SITU INTERROGATION OF MATRIX-COUPLED CHEMICAL COMPOUNDS'
[patent_app_type] => new
[patent_app_number] => 09/448420
[patent_app_country] => US
[patent_app_date] => 1999-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9774
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 471
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090613.pdf
[firstpage_image] =>[orig_patent_app_number] => 09448420
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/448420 | Color-encoding and in-situ interrogation of matrix-coupled chemical compounds | Nov 21, 1999 | Issued |
Array
(
[id] => 4233255
[patent_doc_number] => 06165728
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Antisense modulation of NCK-2 expression'
[patent_app_type] => 1
[patent_app_number] => 9/444053
[patent_app_country] => US
[patent_app_date] => 1999-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27945
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/165/06165728.pdf
[firstpage_image] =>[orig_patent_app_number] => 444053
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/444053 | Antisense modulation of NCK-2 expression | Nov 18, 1999 | Issued |
Array
(
[id] => 1600912
[patent_doc_number] => 06475998
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Methods and compositions for the treatment of injury to the central nervous system'
[patent_app_type] => B1
[patent_app_number] => 09/380532
[patent_app_country] => US
[patent_app_date] => 1999-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 18
[patent_no_of_words] => 15257
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475998.pdf
[firstpage_image] =>[orig_patent_app_number] => 09380532
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380532 | Methods and compositions for the treatment of injury to the central nervous system | Nov 11, 1999 | Issued |
Array
(
[id] => 4406268
[patent_doc_number] => 06271210
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer'
[patent_app_type] => 1
[patent_app_number] => 9/412289
[patent_app_country] => US
[patent_app_date] => 1999-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 10796
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271210.pdf
[firstpage_image] =>[orig_patent_app_number] => 412289
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/412289 | Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer | Oct 4, 1999 | Issued |
Array
(
[id] => 4213496
[patent_doc_number] => 06087112
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Arrays with modified oligonucleotide and polynucleotide compositions'
[patent_app_type] => 1
[patent_app_number] => 9/408088
[patent_app_country] => US
[patent_app_date] => 1999-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 13754
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087112.pdf
[firstpage_image] =>[orig_patent_app_number] => 408088
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/408088 | Arrays with modified oligonucleotide and polynucleotide compositions | Sep 28, 1999 | Issued |
Array
(
[id] => 4411615
[patent_doc_number] => 06300479
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Antibodies specific for human thymosin .beta.15 protein and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/369744
[patent_app_country] => US
[patent_app_date] => 1999-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 21
[patent_no_of_words] => 11830
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300479.pdf
[firstpage_image] =>[orig_patent_app_number] => 369744
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/369744 | Antibodies specific for human thymosin .beta.15 protein and uses thereof | Aug 5, 1999 | Issued |
Array
(
[id] => 4327506
[patent_doc_number] => 06312900
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Antisense oligonucleotide compositions and methods for the modulation of activating protein 1'
[patent_app_type] => 1
[patent_app_number] => 9/364416
[patent_app_country] => US
[patent_app_date] => 1999-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19321
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312900.pdf
[firstpage_image] =>[orig_patent_app_number] => 364416
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/364416 | Antisense oligonucleotide compositions and methods for the modulation of activating protein 1 | Jul 29, 1999 | Issued |
| 09/364790 | HUMAN PHOSPHOLIPASE INHIBITOR | Jul 29, 1999 | Abandoned |
Array
(
[id] => 4236799
[patent_doc_number] => 06080546
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Antisense modulation of MEKK5 expression'
[patent_app_type] => 1
[patent_app_number] => 9/359757
[patent_app_country] => US
[patent_app_date] => 1999-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28133
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080546.pdf
[firstpage_image] =>[orig_patent_app_number] => 359757
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/359757 | Antisense modulation of MEKK5 expression | Jul 22, 1999 | Issued |
Array
(
[id] => 4117323
[patent_doc_number] => 06046308
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Isolated TRBP polypeptides and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/360220
[patent_app_country] => US
[patent_app_date] => 1999-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 43588
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046308.pdf
[firstpage_image] =>[orig_patent_app_number] => 360220
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/360220 | Isolated TRBP polypeptides and uses therefor | Jul 22, 1999 | Issued |
| 09/356069 | ACID STABLE END-BLOCKED NUCLEIC ACIDS AND THERAPEUTIC USES THEREOF | Jul 18, 1999 | Abandoned |
Array
(
[id] => 4355716
[patent_doc_number] => 06291645
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'p62 polypeptides, related polypeptides, and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/357014
[patent_app_country] => US
[patent_app_date] => 1999-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 61
[patent_no_of_words] => 43164
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291645.pdf
[firstpage_image] =>[orig_patent_app_number] => 357014
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/357014 | p62 polypeptides, related polypeptides, and uses therefor | Jul 18, 1999 | Issued |
Array
(
[id] => 4184891
[patent_doc_number] => 06020467
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => 'Antibodies against sulfotransferase'
[patent_app_type] => 1
[patent_app_number] => 9/351438
[patent_app_country] => US
[patent_app_date] => 1999-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12647
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020467.pdf
[firstpage_image] =>[orig_patent_app_number] => 351438
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/351438 | Antibodies against sulfotransferase | Jul 11, 1999 | Issued |
| 09/343809 | HUMAN RNASE H AND COMPOSITIONS AND USES THEREOF | Jun 29, 1999 | Abandoned |
Array
(
[id] => 4087225
[patent_doc_number] => 06162901
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Vesicle transport protein'
[patent_app_type] => 1
[patent_app_number] => 9/334476
[patent_app_country] => US
[patent_app_date] => 1999-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21906
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162901.pdf
[firstpage_image] =>[orig_patent_app_number] => 334476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/334476 | Vesicle transport protein | Jun 15, 1999 | Issued |
Array
(
[id] => 4087343
[patent_doc_number] => 06162909
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Deprotection of RNA'
[patent_app_type] => 1
[patent_app_number] => 9/326154
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5874
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162909.pdf
[firstpage_image] =>[orig_patent_app_number] => 326154
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/326154 | Deprotection of RNA | Jun 3, 1999 | Issued |
Array
(
[id] => 1484916
[patent_doc_number] => 06365396
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Parasite-derived resistance'
[patent_app_type] => B1
[patent_app_number] => 09/315582
[patent_app_country] => US
[patent_app_date] => 1999-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11903
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365396.pdf
[firstpage_image] =>[orig_patent_app_number] => 09315582
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/315582 | Parasite-derived resistance | May 19, 1999 | Issued |
Array
(
[id] => 4212897
[patent_doc_number] => 06110686
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'DNA hybridizing to a human cystatin-like protein (CSTIN)'
[patent_app_type] => 1
[patent_app_number] => 9/314777
[patent_app_country] => US
[patent_app_date] => 1999-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18104
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110686.pdf
[firstpage_image] =>[orig_patent_app_number] => 314777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/314777 | DNA hybridizing to a human cystatin-like protein (CSTIN) | May 18, 1999 | Issued |